Although MRPs are dysregulated in breast cancer patients, including the aforementioned MRPL9, MRPL12, and MRPL13, the specific mechanisms underlying the activity of these proteins in relation to this cancer have yet to be explored. The gene discussed is MRPL13; the disease is breast carcinoma.